The HPV Vaccine

Around The World:

This is not just an issue that is facing the US. Young men and women around the world have suffered because of this vaccine.

Japan

Japanese medical experts issue warning​ against HPV cervical cancer vaccine

Japan de-recommended Gardasil three months after it had added the vaccine to the immunization schedule.

The Japanese government stopped giving the Gardasil vaccine in 2013 after health officials recorded nearly 2,000 adverse reactions, according to the Tokyo Times

That same year, the Japanese Health Ministry published a list of medical institutions where staffs were especially trained to treat patients who had sustained Gardasil-induced injuries.

 

The Japanese government also launched a series of special clinics to evaluate and treat illnesses caused by the Gardasil vaccines.

In 2015 the Japanese Association for Medical Sciences issued official guidelines for managing symptoms of injuries caused by the Gardasil vaccine and the association announced there was no proof that this vaccine even prevents cervical cancer.

Lessons learnt in Japan from adverse reactions to the HPV vaccine: a medical ethics perspective

India

India suspended its Gardasil trials after numerous deaths and serious injuries.

Shortly after the FDA approved Gardasil in June 2006, a US NGO, Program for Appropriate Technology in Health (PATH), started a five year “demonstration project” in India, Uganda, Peru, and Vietnam. In India, the trials took place in two remote provinces: Andhra Pradesh and Gujarat. 

 

Seven girls died in the trials in 2009-10, and many more reported severe health issues following vaccination. This led to an investigation, and a detailed report from the Indian Parliamentary Committee in 2013 found the following:

  • PATH engaged in extraordinary practices to obtain “informed consent” from minors in economically vulnerable areas. The review of thousands of consent forms revealed that they were signed by dormitory supervisors in schools where the girls lived without their parents (but getting parental/guardian consent is required by Indian law). They also found forms with no witness signatures and signatures by thumb impression for those who could not read or write. 

  • Direct interviews revealed that trial participants had received grossly inadequate information about potential risks and benefits while being offered financial inducements to participate. 

  • PATH ignored contraindications when vaccinating girls which was “clearly an act of willful negligence”. Furthermore, their project design failed to provide an independent monitoring agency for adverse events, and PATH also wrongfully used government logos to make the project appear as if it were part of the Indian Universal Immunization Program. 

  • The report concluded that “PATH has exploited with impunity the loopholes in our system” and “has violated all laws and regulations laid down for clinical trials by the Government.”

 

Another report found that families were told that the vaccine would protect the subjects from all cancers; they were not told of any side effects; and they were not provided any medical insurance in the event of injury or death. This report also found that many of the girls suffered from adverse events such as loss of menstrual cycles, depression, and anxiety. The report concluded that “the safety and rights of the children in this vaccination project were highly compromised and violated.” 

 

In October 2012, activists on behalf of the girls in the trials filed a petition in the Indian Supreme Court against the Drug Controller General, the Indian Council of Medical Research, the State of Andhra Pradesh, the State if Gujarat, PATH, GSK, Merck, and others. 

 

This petition alleged that the clinical trials for Gardasil and Cervarix were unethical, that the vaccine use was illegal, and that various actors enlisted girls in an experiment and then abandoned them without follow-up, treatment, or adequate information. The petitioners asked that the Court rescind the Gardasil and Cervarix product licenses in India and withdraw both vaccines from the market until their safety and efficacy was proven.

 

In 2013, the Indian government restricted clinical trials and forced an end to the Merck and GSK “demonstration projects”. 

Columbia

In 2014, 800 girls in the town Carmen de Bolivar were grievously injured by the Gardasil vaccine. Protests erupted all over Columbia. The attorney general of Colombia ordered the National Health Service of that country to immediately begin treating girls who were injured by the Gardasil vaccine.

 

In 2017, Colombia’s highest Constitutional Court ruled that the HPV vaccine would no longer be considered mandatory in Colombia and ordered that girls who showed symptoms after receiving the vaccine be given appropriate medical care.

Pompilio Martinez, who now teaches at the National University of Colombia, described the HPV vaccine as “a crime against humanity.

Denmark

Denmark Documentary - exposing the deaths and permanent injuries of young women after receiving the HPV Vaccine.

Denmark in 2015 announced the opening of five new HPV clinics to treat women who were injured by the Gardasil vaccine. The day that they announced that opening there were 1300 applicants for treatment in those clinics.

Ireland

REGRET - Group of parents in Ireland form the support group REGRET about the HPV vaccine

According to the statistics from the Health Products Regulatory Authority (HPRA), there have been 1,138 reports of adverse events related to HPV vaccination in Ireland and, in 648 of those cases, medical intervention was required.

Sweden

Gardasil vaccination began in Sweden in 2006 and was generalised in 2010, with a vaccination coverage among 12-year-olds of close to 80 percent. There was a catch-up program in 2012-2013 and nearly all Swedish teenagers aged 13-18 were vaccinated.

Interestingly, the Centre for Cervical Cancer Prevention in Sweden states in its 2018 annual report that the incidence of cervical cancer in the country increased by 2 percent each year between 2007 and 2016.

There was a dramatic increase of more than 18 percent in 2014-2016 as compared with 2011-2013, the report states. The incidence rose to 11.43 per 100,000 women.

Statistics from the NORDCAN database indicate that the increase in the incidence of invasive cervical cancer in Sweden is almost entirely due to a rise in incidence among women aged 25 to 49. The incidence increased by more than 19 percent among women aged 20 to 29, by more than 47 percent among those aged 30 to 39, and by nearly 40 percent among those aged 40 to 49. There was, by contrast, a decrease in the incidence of invasive cervical cancer among women in Sweden aged over 50. (The women in this age group did not receive HPV vaccination.)

There has not been a definitive conclusion about the cause of the increased incidence...

U.K.

The U.K has one of the highest rates of HPV vaccination in the world... yet this country is actually seeing an increase in cervical cancer rates (isn't it interesting that countries with the most robust HPV vaccination programs and heavily vaccinated populations are seeing this trend?). Specifically, there has been a 54 per cent rise in cervical cancer rates among 25- to 29-year-olds!! This is extremely alarming and should raise many red flags. 

 

Sanevax - Thousands of parents of HPV Vaccine injured children belong to this non-profit in the U.K. 

Australia

In Australia, in 2015, the Australian Department of Health Therapeutic Goods Administration reported that the adverse rates in girls is 17 times the incidental rate for cervical cancer throughout their lifespan. The country only looked at a handful of conditions including demyelinating disorders, complex regional pain syndrome and premature ovarian failure. There are many, many other injuries that included hospitalizations that were not subject to that study.

Australia is another country where they have actually seen an increase in cervical cancer rates in young women. The Australian National Cancer Registry 2020 data shows a 27% increase in cervical cancers since the vaccine was introduced there. In 20 to 24 year olds incidence more than doubled.  Women too old to be vaccinated showed a decline over the same time frame.